Who is Smart Enough to Decide how to Improve the Human Species?
By Joel Achenbach,
The Washington Post
| 01. 05. 2016
Untitled Document
Which technology promises to most dramatically change our lives? A plausible answer is artificial intelligence -- see part 2 of our series "The Resistance." But a lot of smart people would say biotechnology. Or maybe both, in a glorious scientific tango.
Genetic engineering and molecular biology benefit from the processing power creating by the digital revolution. There's a convergence happening -- and this is arguably one of the biggest stories in the world right now.
Not long ago I walked around Kendall Square with Juan Enriquez. He’s an academic, investor and co-author of “Evolving Ourselves: How Unnatural Selection and Nonrandom Mutation Are Changing Life on Earth." The book's premise: We’re undergoing directed evolution. Darwinian natural selection is giving way to bio-engineering, both the conscious kind in the laboratory and as an unintended consequence of urbanization, changes in lifestyle, the domestication of animals and so on. There's a reason obesity, autism, asthma and other auto-immune diseases are on the rise; these are side-effects of how we are evolving in our modern environment.
As Enriquez and co-author Steve Gullans write...
Related Articles
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...